Keyphrases
Cost-effectiveness
100%
Implantable Defibrillator
100%
Sudden Cardiac Death Prevention
100%
Amiodarone
100%
Quality-adjusted Life Years
40%
Life-years Gained
20%
Marginal Cost
20%
Total Mortality
13%
Lifesaving
13%
High Risk
6%
Mortality Rate
6%
All-cause Mortality
6%
Randomized Trial
6%
Quality of Life
6%
Economic Outcomes
6%
Arrhythmia
6%
Clinical High Risk
6%
Sudden Cardiac Death
6%
Statistical Power
6%
Health Outcomes
6%
Intermediate Risk
6%
Ventricular Arrhythmia
6%
Cost-effectiveness Ratio
6%
Markov Model
6%
Third Generation
6%
Sequential Regimen
6%
Therapy Choice
6%
Medicine and Dentistry
Cost-Effectiveness Analysis
100%
Sudden Cardiac Death
100%
Implantable Automatic Defibrillator
100%
Amiodarone
100%
Quality Adjusted Life Year
40%
Health Care Cost
13%
Lifespan
13%
Mortality Rate
6%
Base
6%
All Cause Mortality
6%
Quality of Life
6%
Cardiac Dysrhythmia
6%
Heart Ventricle Arrhythmia
6%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
Amiodarone
100%
Implantable Cardioverter Defibrillator
100%
Sudden Cardiac Death
100%
Quality Adjusted Life Year
40%
Mortality Rate
6%
Base
6%
Quality of Life
6%
Heart Arrhythmia
6%
All Cause Mortality
6%
Heart Ventricle Arrhythmia
6%
Generator
6%
Pharmacology, Toxicology and Pharmaceutical Science
Amiodarone
100%
Sudden Cardiac Death
100%
Base
10%
Mortality Rate
10%
All Cause Mortality
10%
Heart Arrhythmia
10%
Heart Ventricle Arrhythmia
10%